G6PD表达敲减对人宫颈癌细胞miRNAs表达谱的影响
Effect of G6PD Knockdown on the Expression of miRNAs in Cervical Cancer Cells
-
摘要: 目的 比较G6PD表达敲减后人宫颈癌细胞HPV-C33A与HPV16+Siha以及HPV18+Hela中mi RNAs的表达差异, 进一步了解G6PD致瘤的分子机制。方法 构建G6PD表达敲减的人宫颈癌细胞株, 运用mi RNAs芯片对各细胞株中mi RNAs进行对比分析, q RT-PCR对结果进行验证。结果 (1) 成功获得G6PD表达敲减的人宫颈癌细胞株C33A、Siha和Hela; (2) 与HPV-C33A相比, G6PD表达干扰后高危型HPV16+/18+人宫颈癌细胞株中出现多种mi RNAs差异表达的情况 (P<0.05) 。结论 G6PD在高危型HPV+人宫颈癌中的致瘤性与多种mi RNAs的差异表达相关。
-
关键词:
- 宫颈癌 /
- 高危型人乳头瘤病毒16/18型 /
- G6PD /
- miRNAs
Abstract: Objective To explore the expression changes of miRNAs in HRHPV (16 and 18) infected (+) cervical cancer cells after G6 PD expression knock-down. Methods The G6 PD expression in HPV-C33 A, HPV16+Siha and HPV18+Hela cells was inhibited by RNA interference target G6 PD. Human micro RNA Microarray Kit and q RT-PCR were employed to determine the expression changes of mi RNA between different cell lines.Results The expression of G6 PD significantly decreased after RNA interference in different cervical cancer cell lines.Mi RNA microarrayand q RT-PCR analysis revealed that numerousmiRNAs in HPV+ Hela/Siha cells were expressional different from the control HPV-C33 A cells, following G6 PD knockdown. Conclusion The expression changes of various miRNAs following G6 PDknockdown are associated with the oncogenesis events of G6 PD in HR HPV infected cervical cancer cells.-
Key words:
- Cervical cancer /
- High-risk human papillomavirus (HR HPV) 16/18 infection /
- G6PD /
- miRNAs
-
[1] [1] JEMAL A, BRAY F, CENTER M M, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61 (2) :69-90. [2] [2]ZUR HAUSEN H. Papillomaviruses and cancer:from basic studies to clinical application[J]. Nat Rev Cancer, 2002, 2 (5) :342-350. [3] [3]WALBOOMERS J M, JACOBS M V, MANOS M M, et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J].J Pathol, 1999, 189 (1) :12-19. [4] [4]HU T, LI Y S, CHEN B, et al.Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses[J]. Exp Biol Med (Maywood) , 2015, 240 (10) :1287-1297. [5] [5]HU T, ZHANG C, TANG Q, et al. Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model[J]. BMC Cancer, 2013, 13:251. [6] [6]ZHANG M, DONG B B, LU M, et al. mi R-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells[J]. Onco Targets Ther, 2016, 9:1123-1133. [7]李瑞岩, 蒋传路.脑胶质瘤中G6PD蛋白的表达及与肿瘤分级的相关性[J].黑龙江医学, 2008, 32 (8) :573-575. [8] [8]KEKEC Y, PAYDAS S, TULI A, et al. Antioxidant enzyme levels in cases with gastrointesinal cancer[J]. Eur J Intern Med, 2009, 20 (4) :403-406. [9] [9]LANGBEIN S, FREDERIKS W M, ZUR HAUSEN A, et al.Metastasis is promoted by a bioenergetic switch:New targets for progressive renal cell cancer[J]. Cancer, 2008, 12 (2) :2422-2428. [10] [10]GERACI G, D'ELIA I, GAUDIO R. Evidence of genetic instability in tumors and normal nearby tissues[J]. PLo S ONE, 2010, 5 (2) :e9343. [11] [11]KOUDSTAAL J, MAKKINK B, OVERDIEP S H. Enzyme histochemical pattern in human tumours. II. Oxidoreductases in carcinoma of the colon and the breast[J]. Eur J Cancer, 1975, 11 (2) :111-115. [12] [12]BAHA M, YAMAOTO R, IISHI H, et al. Role of glucose-6-phosphate dehydrogenase on enhanced proliferation of pre-neoplastic and neoplastic cells in rat liver induced by N-nitrosomorpholine[J]. Int J Cancer, 1989, 43 (5) :892-895. [13] [13]HU T, CHANG YF, XIAO Z, et al. mi R-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD[J].Oncotarget, 2016, 7 (52) :86103-86116. [14] [14]JOHN B, EERIGHT AJ, ARAVIN A, et al. Human MicroRNA targets[J]. PLo S Biol, 2004, 2 (11) :e363. [15] [15]SATOH J. Molecular network analysis of human micro RNA targetome:from cancers to Alzheimer’s disease[J]. Bio Data Min, 2012, 5 (1) :17. [16] [16]FUJII R, OSAKA E, SATO K, TOKUHASHI Y, et al.Mi R-1 Suppresses Proliferation of Osteosarcoma Cells by Up-regulating p21 via PAX3[J].Cancer Genomics Proteomics, 2019, 16 (1) :71-79. [17] [17]DU YY, ZHAO LM, CHEN L, et al. The tumor-suppressive function of mi R-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma[J]. J GastroenterolHepatol, 2015, 31 (2) :384-393. [18] [18]XU X, WU X, JIANG Q, et al. Downregulation of micro RNA-1 and micro RNA-145 contributes synergistically to the development of colon cancer[J]. Int J Mol Med, 2015, 36 (6) :1630-1638. [19] [19]KORI M, YALCIN ARGA K.Potential biomarkers and therapeutic targets in cervical cancer:Insights from the meta-analysis of transcriptomics data within network biomedicine perspective[J].PLo S One, 2018, 13 (7) :e0200717. [20] [20]LIANG H, LI Y, LUO RY, et al. MicroRNA-215 is a potential prognostic marker for cervical cancer[J]. J Huazhong Univ Sc i Technolog Med Sci, 2014, 34 (2) :207-212. [21] [21] LIANG H, LI Y, LUO RY, et al.MicroRNA-215 is a potential prognostic marker for cervical cancer[J].J Huazhong Univ Sci Technolog Med Sci, 2014, 34 (2) :207-212. [22] [22]SONG R, CONG L, NI G, et al.MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF[J].Oncol Lett, 2017, 14 (1) :767-775. [23] [23]WANG R, ZHAO N, LI S, et al. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42[J]. Hepatology, 2013, 58 (2) :642-653. [24] [24]ZHOU Q, HAN LR, ZHOU YX, et al.MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3[J].Int J Gynecol Cancer, 2016, 26 (5) :817-824.
点击查看大图
计量
- 文章访问数: 2919
- HTML全文浏览量: 1084
- PDF下载量: 48
- 被引次数: 0